nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC18A2—schizophrenia	0.567	0.707	CbGaD
Lisdexamfetamine—SLC6A3—schizophrenia	0.235	0.293	CbGaD
Lisdexamfetamine—SLC6A2—locus ceruleus—schizophrenia	0.01	0.166	CbGeAlD
Lisdexamfetamine—SLC18A2—telencephalic ventricle—schizophrenia	0.00781	0.129	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalic ventricle—schizophrenia	0.00591	0.0973	CbGeAlD
Lisdexamfetamine—SLC6A2—autonomic nervous system—schizophrenia	0.00534	0.088	CbGeAlD
Lisdexamfetamine—SLC18A2—blood plasma—schizophrenia	0.00372	0.0613	CbGeAlD
Lisdexamfetamine—SLC18A2—forebrain—schizophrenia	0.00204	0.0336	CbGeAlD
Lisdexamfetamine—SLC18A2—telencephalon—schizophrenia	0.00187	0.0309	CbGeAlD
Lisdexamfetamine—SLC6A3—forebrain—schizophrenia	0.00154	0.0254	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalon—schizophrenia	0.00142	0.0234	CbGeAlD
Lisdexamfetamine—SLC18A2—blood—schizophrenia	0.00136	0.0225	CbGeAlD
Lisdexamfetamine—SLC18A2—midbrain—schizophrenia	0.00135	0.0222	CbGeAlD
Lisdexamfetamine—SLC6A2—forebrain—schizophrenia	0.00124	0.0205	CbGeAlD
Lisdexamfetamine—SLC18A2—endocrine gland—schizophrenia	0.00118	0.0195	CbGeAlD
Lisdexamfetamine—SLC6A2—telencephalon—schizophrenia	0.00114	0.0189	CbGeAlD
Lisdexamfetamine—ADRA1B—nervous system—schizophrenia	0.00112	0.0184	CbGeAlD
Lisdexamfetamine—SLC18A2—nervous system—schizophrenia	0.00111	0.0182	CbGeAlD
Lisdexamfetamine—ADRA1B—central nervous system—schizophrenia	0.00108	0.0177	CbGeAlD
Lisdexamfetamine—SLC18A2—central nervous system—schizophrenia	0.00107	0.0176	CbGeAlD
Lisdexamfetamine—SLC18A2—cerebellum—schizophrenia	0.00104	0.0172	CbGeAlD
Lisdexamfetamine—SLC6A3—midbrain—schizophrenia	0.00102	0.0168	CbGeAlD
Lisdexamfetamine—SLC6A2—gonad—schizophrenia	0.000955	0.0157	CbGeAlD
Lisdexamfetamine—ADRA1B—brain—schizophrenia	0.000854	0.0141	CbGeAlD
Lisdexamfetamine—SLC18A2—brain—schizophrenia	0.000846	0.0139	CbGeAlD
Lisdexamfetamine—SLC6A3—nervous system—schizophrenia	0.000837	0.0138	CbGeAlD
Lisdexamfetamine—SLC6A3—central nervous system—schizophrenia	0.000806	0.0133	CbGeAlD
Lisdexamfetamine—SLC6A3—cerebellum—schizophrenia	0.000788	0.013	CbGeAlD
Lisdexamfetamine—SLC6A2—endocrine gland—schizophrenia	0.000722	0.0119	CbGeAlD
Lisdexamfetamine—SLC6A2—nervous system—schizophrenia	0.000675	0.0111	CbGeAlD
Lisdexamfetamine—SLC6A2—central nervous system—schizophrenia	0.00065	0.0107	CbGeAlD
Lisdexamfetamine—SLC6A3—brain—schizophrenia	0.00064	0.0105	CbGeAlD
Lisdexamfetamine—Dextroamphetamine—SLC18A2—schizophrenia	0.00061	0.112	CrCbGaD
Lisdexamfetamine—L-Phenylalanine—TH—schizophrenia	0.000576	0.105	CrCbGaD
Lisdexamfetamine—SLC6A2—brain—schizophrenia	0.000516	0.00851	CbGeAlD
Lisdexamfetamine—Amphetamine—SLC18A2—schizophrenia	0.000492	0.0899	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC18A2—schizophrenia	0.000456	0.0833	CrCbGaD
Lisdexamfetamine—Lisinopril—ACE—schizophrenia	0.00042	0.0768	CrCbGaD
Lisdexamfetamine—Selegiline—MAOA—schizophrenia	0.000285	0.052	CrCbGaD
Lisdexamfetamine—Dextroamphetamine—SLC6A3—schizophrenia	0.000253	0.0463	CrCbGaD
Lisdexamfetamine—Phenelzine—MAOA—schizophrenia	0.000251	0.0458	CrCbGaD
Lisdexamfetamine—Methamphetamine—MAOA—schizophrenia	0.000219	0.0401	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC6A3—schizophrenia	0.000204	0.0373	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC6A3—schizophrenia	0.000189	0.0346	CrCbGaD
Lisdexamfetamine—Labetalol—CYP2D6—schizophrenia	0.000177	0.0324	CrCbGaD
Lisdexamfetamine—Selegiline—CYP1A2—schizophrenia	0.000167	0.0306	CrCbGaD
Lisdexamfetamine—Lisinopril—ABCB1—schizophrenia	0.000164	0.03	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC6A4—schizophrenia	0.000153	0.0279	CrCbGaD
Lisdexamfetamine—Amphetamine—DRD2—schizophrenia	0.000152	0.0277	CrCbGaD
Lisdexamfetamine—Methamphetamine—SLC6A4—schizophrenia	0.000141	0.0258	CrCbGaD
Lisdexamfetamine—Dextroamphetamine—CYP2D6—schizophrenia	0.000133	0.0243	CrCbGaD
Lisdexamfetamine—Selegiline—CYP2D6—schizophrenia	0.000129	0.0236	CrCbGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—GSTP1—schizophrenia	0.000116	0.000876	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.000115	0.000871	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CHRNA4—schizophrenia	0.000113	0.000861	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIK2—schizophrenia	0.000113	0.00086	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CHRM1—schizophrenia	0.000113	0.000858	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—GSK3B—schizophrenia	0.000113	0.000856	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—FOS—schizophrenia	0.000112	0.000851	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—schizophrenia	0.000111	0.000844	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIN1—schizophrenia	0.000111	0.000842	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SLC18A2—schizophrenia	0.00011	0.000833	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR6—schizophrenia	0.00011	0.000832	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GAD1—schizophrenia	0.000109	0.000825	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CHRNA3—schizophrenia	0.000109	0.000825	CbGpPWpGaD
Lisdexamfetamine—Amphetamine—CYP2D6—schizophrenia	0.000107	0.0196	CrCbGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—schizophrenia	0.000107	0.000811	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—HTR3A—schizophrenia	0.000107	0.00081	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—schizophrenia	0.000107	0.000809	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—FZD3—schizophrenia	0.000107	0.000808	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—GSTM1—schizophrenia	0.000106	0.000805	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—SNAP25—schizophrenia	0.000106	0.0008	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—OXT—schizophrenia	0.000104	0.000791	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—NRG1—schizophrenia	0.000104	0.00079	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—HSPA8—schizophrenia	0.000104	0.000789	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—COMT—schizophrenia	0.000103	0.000779	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—GSTP1—schizophrenia	0.000102	0.000776	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—MAOA—schizophrenia	0.000102	0.000774	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CACNB2—schizophrenia	0.000101	0.000767	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIA1—schizophrenia	0.000101	0.000767	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SLC6A1—schizophrenia	0.000101	0.000767	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIN2A—schizophrenia	0.000101	0.000767	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CAMK2B—schizophrenia	0.000101	0.000767	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GRM2—schizophrenia	0.0001	0.000759	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TAAR6—schizophrenia	0.0001	0.000759	CbGpPWpGaD
Lisdexamfetamine—Methamphetamine—CYP2D6—schizophrenia	9.94e-05	0.0182	CrCbGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—NPS—schizophrenia	9.89e-05	0.00075	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—DLG4—schizophrenia	9.76e-05	0.00074	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2C—schizophrenia	9.7e-05	0.000735	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CHRM1—schizophrenia	9.7e-05	0.000735	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CHRNB2—schizophrenia	9.58e-05	0.000726	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—schizophrenia	9.54e-05	0.000724	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC1A1—schizophrenia	9.52e-05	0.000722	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—HTR3A—schizophrenia	9.47e-05	0.000718	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—GSTM1—schizophrenia	9.41e-05	0.000713	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—OXT—schizophrenia	9.33e-05	0.000707	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—NRG1—schizophrenia	9.23e-05	0.0007	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CCKAR—schizophrenia	9.23e-05	0.000699	CbGpPWpGaD
Lisdexamfetamine—Selegiline—ABCB1—schizophrenia	9.22e-05	0.0168	CrCbGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—schizophrenia	9.12e-05	0.000692	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NTS—schizophrenia	9.06e-05	0.000687	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—ADORA2A—schizophrenia	8.95e-05	0.000678	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—schizophrenia	8.84e-05	0.000671	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC17A7—schizophrenia	8.71e-05	0.000661	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CHRNA4—schizophrenia	8.7e-05	0.000659	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—schizophrenia	8.67e-05	0.000658	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—schizophrenia	8.61e-05	0.000653	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GRM3—schizophrenia	8.52e-05	0.000646	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC1A1—schizophrenia	8.44e-05	0.00064	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR6—schizophrenia	8.36e-05	0.000634	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCK—schizophrenia	8.24e-05	0.000625	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ATP2A2—schizophrenia	8.13e-05	0.000616	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SNAP25—schizophrenia	8.08e-05	0.000613	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—schizophrenia	8.06e-05	0.000611	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—COMT—schizophrenia	8e-05	0.000606	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—HSPA8—schizophrenia	7.97e-05	0.000604	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—schizophrenia	7.94e-05	0.000602	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCKAR—schizophrenia	7.9e-05	0.000599	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—schizophrenia	7.76e-05	0.000589	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—GABRB2—schizophrenia	7.73e-05	0.000586	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC17A7—schizophrenia	7.72e-05	0.000585	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADORA2A—schizophrenia	7.66e-05	0.000581	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—YWHAZ—schizophrenia	7.58e-05	0.000575	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD1—schizophrenia	7.5e-05	0.000568	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—schizophrenia	7.5e-05	0.000568	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—DLG4—schizophrenia	7.48e-05	0.000567	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CHRM1—schizophrenia	7.38e-05	0.00056	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIN2B—schizophrenia	7.31e-05	0.000554	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—schizophrenia	7.26e-05	0.00055	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPY—schizophrenia	7.16e-05	0.000543	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DGKI—schizophrenia	7.08e-05	0.000537	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—schizophrenia	7.05e-05	0.000534	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	6.91e-05	0.000524	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	6.91e-05	0.000524	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—GRM5—schizophrenia	6.86e-05	0.00052	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—GABRB2—schizophrenia	6.84e-05	0.000519	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	6.73e-05	0.00051	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC18A2—schizophrenia	6.67e-05	0.000506	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	6.65e-05	0.000504	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	6.57e-05	0.000498	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	6.57e-05	0.000498	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	6.55e-05	0.000497	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.5e-05	0.000493	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DGKI—schizophrenia	6.43e-05	0.000487	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	6.42e-05	0.000487	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	6.42e-05	0.000487	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCK—schizophrenia	6.28e-05	0.000476	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	6.22e-05	0.000472	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—schizophrenia	6.14e-05	0.000465	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—COMT—schizophrenia	6.13e-05	0.000465	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—MAOA—schizophrenia	6.08e-05	0.000461	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	6.04e-05	0.000458	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CCKAR—schizophrenia	6.02e-05	0.000456	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2A—schizophrenia	5.95e-05	0.000451	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC18A2—schizophrenia	5.91e-05	0.000448	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PPP1R1B—schizophrenia	5.88e-05	0.000446	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADORA2A—schizophrenia	5.84e-05	0.000443	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	5.77e-05	0.000437	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TAAR6—schizophrenia	5.66e-05	0.000429	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GRM2—schizophrenia	5.66e-05	0.000429	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	5.63e-05	0.000427	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	5.63e-05	0.000427	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ATP2A2—schizophrenia	5.47e-05	0.000415	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—FZD3—schizophrenia	5.47e-05	0.000414	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NPY—schizophrenia	5.45e-05	0.000413	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—schizophrenia	5.44e-05	0.000412	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—schizophrenia	5.32e-05	0.000403	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1B—schizophrenia	5.26e-05	0.000399	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—OXT—schizophrenia	5.26e-05	0.000399	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NGEF—schizophrenia	5.24e-05	0.000397	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ABCB1—schizophrenia	5.21e-05	0.000395	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PPP3CC—schizophrenia	5.14e-05	0.00039	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TAAR6—schizophrenia	5.14e-05	0.00039	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GRM2—schizophrenia	5.14e-05	0.00039	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NTS—schizophrenia	5.12e-05	0.000388	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1A—schizophrenia	5.06e-05	0.000384	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—TP53—schizophrenia	5.01e-05	0.00038	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—NPS—schizophrenia	4.99e-05	0.000378	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD1—schizophrenia	4.89e-05	0.000371	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2C—schizophrenia	4.89e-05	0.000371	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ATP2A2—schizophrenia	4.85e-05	0.000367	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GRM3—schizophrenia	4.81e-05	0.000365	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RGS4—schizophrenia	4.81e-05	0.000365	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NGEF—schizophrenia	4.76e-05	0.000361	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD3—schizophrenia	4.74e-05	0.000359	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR6—schizophrenia	4.72e-05	0.000358	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NTS—schizophrenia	4.65e-05	0.000352	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	4.6e-05	0.000349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD4—schizophrenia	4.6e-05	0.000349	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—AKT1—schizophrenia	4.49e-05	0.000341	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—CNR1—schizophrenia	4.39e-05	0.000333	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—schizophrenia	4.37e-05	0.000332	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GRM3—schizophrenia	4.37e-05	0.000331	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RGS4—schizophrenia	4.37e-05	0.000331	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR6—schizophrenia	4.29e-05	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD2—schizophrenia	4.28e-05	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR7—schizophrenia	4.28e-05	0.000325	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—AMPK Signaling—AKT1—schizophrenia	4.23e-05	0.000321	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CHRM1—schizophrenia	4.17e-05	0.000316	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—APOA1—schizophrenia	4.11e-05	0.000312	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—IL3RA—schizophrenia	4.07e-05	0.000308	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	3.94e-05	0.000299	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—GRM5—schizophrenia	3.88e-05	0.000294	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DGKI—schizophrenia	3.8e-05	0.000288	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CHRM1—schizophrenia	3.79e-05	0.000287	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—IL3RA—schizophrenia	3.69e-05	0.00028	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCK—schizophrenia	3.55e-05	0.000269	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—GRM5—schizophrenia	3.52e-05	0.000267	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.5e-05	0.000266	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPP1R1B—schizophrenia	3.47e-05	0.000263	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4B—schizophrenia	3.46e-05	0.000262	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CCKAR—schizophrenia	3.4e-05	0.000258	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADORA2A—schizophrenia	3.3e-05	0.00025	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FZD3—schizophrenia	3.23e-05	0.000245	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCK—schizophrenia	3.22e-05	0.000244	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4B—schizophrenia	3.14e-05	0.000238	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ABCB1—schizophrenia	3.1e-05	0.000235	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CCKAR—schizophrenia	3.09e-05	0.000234	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NPY—schizophrenia	3.08e-05	0.000234	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FES—schizophrenia	3.04e-05	0.00023	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PPP3CC—schizophrenia	3.04e-05	0.00023	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GRM2—schizophrenia	3.04e-05	0.00023	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TAAR6—schizophrenia	3.04e-05	0.00023	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2A—schizophrenia	3e-05	0.000227	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADORA2A—schizophrenia	3e-05	0.000227	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1B—schizophrenia	2.97e-05	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—OXT—schizophrenia	2.97e-05	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1A—schizophrenia	2.86e-05	0.000217	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—NPS—schizophrenia	2.82e-05	0.000214	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NGEF—schizophrenia	2.81e-05	0.000213	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NPY—schizophrenia	2.8e-05	0.000212	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—APOA1—schizophrenia	2.77e-05	0.00021	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2C—schizophrenia	2.76e-05	0.00021	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD1—schizophrenia	2.76e-05	0.00021	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NTS—schizophrenia	2.75e-05	0.000208	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1B—schizophrenia	2.7e-05	0.000205	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—OXT—schizophrenia	2.7e-05	0.000205	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD3—schizophrenia	2.68e-05	0.000203	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1A—schizophrenia	2.6e-05	0.000197	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD4—schizophrenia	2.6e-05	0.000197	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RTN4—schizophrenia	2.58e-05	0.000196	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GRM3—schizophrenia	2.58e-05	0.000196	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RGS4—schizophrenia	2.58e-05	0.000196	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—NPS—schizophrenia	2.56e-05	0.000194	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR6—schizophrenia	2.53e-05	0.000192	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD1—schizophrenia	2.51e-05	0.00019	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2C—schizophrenia	2.51e-05	0.00019	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—CNR1—schizophrenia	2.48e-05	0.000188	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—APOA1—schizophrenia	2.45e-05	0.000186	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MAG—schizophrenia	2.45e-05	0.000186	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD3—schizophrenia	2.43e-05	0.000184	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD2—schizophrenia	2.42e-05	0.000184	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR7—schizophrenia	2.42e-05	0.000184	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD4—schizophrenia	2.36e-05	0.000179	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—CNR1—schizophrenia	2.25e-05	0.000171	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CHRM1—schizophrenia	2.24e-05	0.00017	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR7—schizophrenia	2.2e-05	0.000167	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD2—schizophrenia	2.2e-05	0.000167	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—IL3RA—schizophrenia	2.18e-05	0.000165	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NRG3—schizophrenia	2.13e-05	0.000161	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TLE1—schizophrenia	2.13e-05	0.000161	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GFAP—schizophrenia	2.1e-05	0.00016	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GRM5—schizophrenia	2.08e-05	0.000158	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TLE3—schizophrenia	2.02e-05	0.000153	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCK—schizophrenia	1.9e-05	0.000144	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4B—schizophrenia	1.85e-05	0.000141	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CCKAR—schizophrenia	1.82e-05	0.000138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADORA2A—schizophrenia	1.77e-05	0.000134	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PLA2G4A—schizophrenia	1.74e-05	0.000132	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—FGA—schizophrenia	1.7e-05	0.000129	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2A—schizophrenia	1.7e-05	0.000129	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPY—schizophrenia	1.65e-05	0.000125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NOTCH4—schizophrenia	1.65e-05	0.000125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ATP2A2—schizophrenia	1.65e-05	0.000125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1B—schizophrenia	1.59e-05	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—OXT—schizophrenia	1.59e-05	0.000121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2A—schizophrenia	1.54e-05	0.000117	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1A—schizophrenia	1.54e-05	0.000116	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NPS—schizophrenia	1.51e-05	0.000115	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2C—schizophrenia	1.48e-05	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD1—schizophrenia	1.48e-05	0.000112	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NTRK2—schizophrenia	1.44e-05	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD3—schizophrenia	1.44e-05	0.000109	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD4—schizophrenia	1.39e-05	0.000106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—CNR1—schizophrenia	1.33e-05	0.000101	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR7—schizophrenia	1.3e-05	9.85e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD2—schizophrenia	1.3e-05	9.85e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PRL—schizophrenia	1.23e-05	9.3e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—S100B—schizophrenia	1.14e-05	8.67e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ERBB4—schizophrenia	1.09e-05	8.29e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PLA2G4A—schizophrenia	1.03e-05	7.79e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NRG1—schizophrenia	1.01e-05	7.65e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—MEF2C—schizophrenia	1e-05	7.58e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—YWHAZ—schizophrenia	9.66e-06	7.33e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ERBB3—schizophrenia	9.45e-06	7.17e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2A—schizophrenia	9.1e-06	6.9e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOE—schizophrenia	8.46e-06	6.41e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—APOA1—schizophrenia	8.36e-06	6.34e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ESR1—schizophrenia	8.07e-06	6.12e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GSK3B—schizophrenia	7.32e-06	5.55e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—AKT1—schizophrenia	5.43e-06	4.12e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—AKT1—schizophrenia	4.93e-06	3.74e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—EP300—schizophrenia	4.82e-06	3.65e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TP53—schizophrenia	3.45e-06	2.61e-05	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AKT1—schizophrenia	2.91e-06	2.21e-05	CbGpPWpGaD
